STAT

Research is scarce on medication use in pregnant women. Experts are urging the government to fix that

An expert panel formed by Congress is urging the federal government to include more pregnant and lactating women in clinical trials.
Source: LOIC VENANCE/AFP/Getty Images

There’s very little research on whether medications are safe and effective in pregnant and lactating women, but an expert panel has ideas for how to close that information gap — and it’s calling on the federal government to take action in a new report that could stir change.

The sweeping report is the product of more than a year of public meetings by a task force formed by Congress in 2016 to study why so few women can get while pregnant and lactating. More than 6 million women are pregnant in the U.S. each year, and it’s estimated that more than 90 percent take at least one medication while pregnant or lactating. But few

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks